scholarly journals The 2016 Vaccine Development Pipeline: A special issue from the World Health Organization Product Development for Vaccine Advisory Committee (PDVAC)

Vaccine ◽  
2016 ◽  
Vol 34 (26) ◽  
pp. 2863-2864 ◽  
Author(s):  
Birgitte K. Giersing ◽  
Kayvon Modjarrad ◽  
David C. Kaslow ◽  
Jean-Marie Okwo-Bele ◽  
Vasee S. Moorthy
2008 ◽  
Vol 14 (2) ◽  
pp. 7
Author(s):  
Russell Renhard ◽  
Steve Einfeld

This is the first occasion the Journal has published a special issue on safety and quality in primary health, although of course individual articles on the subject have appeared in its pages. The timing of the issue reflects significant world-wide interest evidenced in a growth of specialist safety and quality-related journals, conferences, World Health Organization programs, as well as policy initiatives by governments all over the world.


2005 ◽  
Vol 10 (2) ◽  
Author(s):  
Collective Editorial team

The World Health Organization (WHO) Global Advisory Committee on Vaccine Safety was established in 1999 to respond promptly, efficiently, and with scientific rigour to vaccine safety issues of potential global importance. In 2003, GACVS launched the Vaccine Safety Net project.


Author(s):  
Annalisa Guarini ◽  
Miguel Pérez Pereira ◽  
Anneloes van Baar ◽  
Alessandra Sansavini

As indicated by the World Health Organization, preterm birth is a relevant public health issue, being one of the leading causes of death in children under five years of age [...]


1990 ◽  
Vol 31 (1) ◽  
pp. 62-64 ◽  
Author(s):  
T. Bektimirov ◽  
P.-H. Lambert ◽  
G. Torrigiani

2020 ◽  
Vol 17 (5) ◽  
pp. 467-471 ◽  
Author(s):  
Susan S Ellenberg

The first rumblings about a new coronavirus spreading in China were heard in January 2020. By the end of that month, the World Health Organization, recognizing the severity of the disease and the potential for global spread, had declared a public health emergency. By February 2020, cases had been identified in multiple countries, clinical trials of treatments with some biological plausibility had begun in China, and the initial steps of vaccine development were underway. In mid-March, by which time countries around the world were experiencing rapidly increasing numbers of cases and deaths, the World Health Organization categorized the outbreak as a pandemic. This new coronavirus was designated SARS-COV-2 in recognition of its similarity to the coronavirus responsible for the severe acute respiratory syndrome outbreak in 2002–2003. The race is on to develop treatments that can mitigate the severe consequences of infection and vaccines that can prevent infection and/or diminish the severity of disease in those who do get infected. Many challenges face these development efforts. Some are similar to those faced in the past; others are new. The urgency of finding ways to treat, and ultimately prevent, the consequences of this new and potentially deadly infection has led to unprecedented focus on clinical trials.


2021 ◽  
Vol 49 (1) ◽  
Author(s):  
Amal A. El-Moamly

Abstract Background Scabies is an under-recognized global health problem with an unacceptably high prevalence in many settings worldwide. Fortunately, the World Health Organization (WHO) has formally designated scabies as a neglected tropical disease in 2017, in the hope of increasing awareness and encouraging efforts to eradicate it. Also, scabies has recently been included as part of the WHO roadmap for neglected tropical diseases 2021–2030, aimed at ending the neglect to attain the Sustainable Development Goals. Main abstract body This review article places scabies in focus. The literature was reviewed to explore discussions on controversial issues in scabies control, with the aim of clarifying whether global control of scabies is a feasible and worthwhile objective. The existing status of scabies and its burden are discussed along with future prospects for its global control. The article investigates the feasibility of scabies control and provides updates on the various impediments to this goal, such as challenges related to transmission, diagnosis, treatment, and vaccine development. Also examined are relevant research needs, success factors, and reasons for failure. This article aims to increase the global awareness of scabies and promote discussion, enhance coordinated international efforts, and ultimately, enact change at the national and worldwide levels toward the control of this preventable disease of the poor. Conclusion Despite the current challenges, scabies control is now within reach. With sustained interventions, continuous resources, and sincere commitment and support, scabies global control appears to be a worthwhile, realistic goal that is potentially achievable in the not so distant future.


Sign in / Sign up

Export Citation Format

Share Document